Filing Details
- Accession Number:
- 0001209191-21-051396
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-13 16:27:16
- Reporting Period:
- 2021-08-11
- Accepted Time:
- 2021-08-13 16:27:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1426332 | Ngm Biopharmaceuticals Inc | NGM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1468482 | D Hsiao Lieu | 333 Oyster Point Boulevard South San Francisco CA 94080 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-11 | 2,258 | $23.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-08-12 | 8,000 | $12.06 | 8,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-12 | 8,000 | $23.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-08-12 | 8,000 | $0.00 | 8,000 | $12.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 192,000 | 2029-03-18 | No | 4 | M | Direct |
Footnotes
- Includes 183 and 1,893 shares purchased through the Issuer's employee stock purchase plan on 11/13/2020 and 5/14/2021, respectively.
- The shares subject to the stock option vest over a four-year period measured from the grant date, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
